SAN DIEGO, Jan. 10, 2024 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on January 10, 2024, the Compensation Committee of Crinetics’ Board of Directors granted non-qualified stock option awards to purchase an aggregate of 112,500 shares of its common stock to eight new non-executive employees under the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan (the “2021 Inducement Plan”). The stock options were granted as inducements material to the employees entering into employment with Crinetics in accordance with Nasdaq Listing Rule 5635(c)(4).
GlobeNewswire,is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Latest posts by GlobeNewswire (see all)
- Pixalate’s March 2025 Top Grossing Mobile Apps in APAC: ‘SimCity’ Ranked No. 1 on Google Play Store in Japan; ‘OLX’ Led on Apple App Store in India; ‘Sudoku’ Ranked No. 1 on Apple App Store in Singapore - April 21, 2025
- Pixalate’s March 2025 Top Grossing Mobile & CTV Apps in LATAM: ‘ViX’ No. 1 on Roku, Amazon Fire TV & Samsung Smart TV in Mexico; ‘Space shooter’ Leads in Brazil on Google Play Store - April 21, 2025
- Pixalate’s March 2025 Top Grossing Mobile & CTV Apps in EMEA: ‘Block Blast!’ Tops Apple App Store in UK, Germany, Netherlands; ‘Hulu’ Led on Roku in UK - April 21, 2025
